PA
BEAM icon

Profund Advisors’s Beam Therapeutics BEAM Stock Holding History

Profund Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
47,584
-29,511
-38% -$891K 0.04% 246
2026
Q1 		$1.84M Buy
77,095
+11,478
+17% +$318K 0.07% 225
2025
Q4 		$1.82M Buy
65,617
+35,571
+118% +$908K 0.06% 233
2025
Q3 		$729K Buy
30,046
+3,863
+15% +$76.8K 0.02% 401
2025
Q2 		$445K Buy
26,183
+758
+3% +$13.2K 0.02% 502
2025
Q1 		$497K Buy
25,425
+3,314
+15% +$86.8K 0.02% 474
2024
Q4 		$548K Sell
22,111
-14,876
-40% -$380K 0.02% 473
2024
Q3 		$906K Buy
36,987
+6,119
+20% +$158K 0.03% 345
2024
Q2 		$723K Sell
30,868
-7,768
-20% -$191K 0.03% 387
2024
Q1 		$1.28M Sell
38,636
-16,730
-30% -$521K 0.05% 295
2023
Q4 		$1.51M Sell
55,366
-1,951
-3% -$48.5K 0.06% 245
2023
Q3 		$1.38M Buy
57,317
+10,163
+22% +$272K 0.08% 213
2023
Q2 		$1.51M Buy
47,154
+7,447
+19% +$242K 0.08% 202
2023
Q1 		$1.22M Buy
39,707
+31,589
+389% +$1.25M 0.08% 253
2022
Q4 		$317K Buy
8,118
+169
+2% +$7.57K 0.02% 615
2022
Q3 		$379K Buy
7,949
+1,297
+19% +$74K 0.03% 479
2022
Q2 		$257K Sell
6,652
-465
-7% -$18.5K 0.02% 735
2022
Q1 		$408K Sell
7,117
-800
-10% -$52.5K 0.02% 706
2021
Q4 		$631K Sell
7,917
-644
-8% -$55.1K 0.02% 485
2021
Q3 		$745K Buy
+8,561
New +$860K 0.03% 458

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Profund Advisors's BEAM Position: Q2 2026 in Review

Profund Advisors reduced its Beam Therapeutics (BEAM) stake by 38% in Q2 2026, selling an estimated $891K and leaving 47,584 shares worth $1.63M. The position accounts for 0.04% of the portfolio, ranked #246.

Profund Advisors first reported a position in BEAM in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.84M in Q1 2026. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Profund Advisors held 47,584 shares of Beam Therapeutics worth $1.63M as of Q2 2026.
  • Profund Advisors sold 29,511 Beam Therapeutics shares in Q2 2026, an estimated $891K.
  • Beam Therapeutics made up 0.04% of Profund Advisors's portfolio in Q2 2026, its #246 holding.
  • Profund Advisors first reported a position in Beam Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Profund Advisors's Beam Therapeutics position peaked at $1.84M in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.